AgomAb Therapeutics NV (AGMB) Accounts Payables (2024 - 2026)
Agomab Therapeutics (AGMB) reported Accounts Payables of $13.77 million for Q2 2026.
Powered by 
Analysis
AgomAb Therapeutics NV (AGMB) Accounts Payables (2024 - 2026) Analysis & Trends
At the end of FY2025, Agomab Therapeutics posted Accounts Payables of $11.6 million, up 33.1% from FY2024.
- By year, Accounts Payables came in at $8.71 million in FY2024.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.53 Mn |
| Dec 31, 2025 | 12.06 Mn |
| Dec 31, 2024 | 8.38 Mn |
API Access
AgomAb Therapeutics NV Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=AGMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "AGMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=AGMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();